Genea Biomedx and Hamilton Thorne partner to grow Genea Biomedx operations and support customers in USA and Canada

12 NOVEMBER 2020, SYDNEY, AUSTRALIA: Australian fertility innovator Genea Biomedx has entered into a collaboration agreement with Hamilton Thorne Ltd, a leading provider of products and services to the Assisted Reproductive Technologies markets. Under the terms of the collaboration agreement, Hamilton Thorne will exclusively commercialize and market Genea Biomedx’s flagship fertility technologies and products in the United States and Canada.

Through this collaboration Genea Biomedx and Hamilton Thorne will build on the existing momentum established by the Fertility Technologies group at EMD Serono in the US and Canada.

“Our mission is to improve ART success rates through the continuing development of standardized technologies. We believe that our unique relationship with Hamilton Thorne will give us the opportunity to further support our existing customers, and to meet the growing demand for our technologies in US and Canada at the same time.” says Louis Villalba, Genea Biomedx CEO.

Genea Biomedx has been developing innovative fertility technologies for automation of laboratory workflows since 2013. Being part of the Genea IVF family has given Genea Biomedx access to valuable resources whose insight and knowledge continuously contribute to converting clinical challenges into new, practical solutions for the modern IVF laboratory.
Download a PDF of the press release

Media Contact

Louis Villalba
M: +1 (650) 421 5758
E: louis.villalba@geneabiomedx.com


About Genea and Genea Biomedx
Genea is one of Australia’s leading and pioneering providers for infertility, IVF and other assisted conception treatment with 33 years of experience in the field including in-house developed research and technologies virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. 
Genea Biomedx creates and manufactures practical, accessible and precise fertility technologies that help standardise and automate fertility treatment. Its unique relationship with Genea Fertility means that Genea Biomedx is a manufacturer that truly understands the customers’ perspective.

About Geri, Gems, Gidget and Gavi
  • Geri - a humidified time-lapse incubator with individually controlled incubation chambers per patient to minimize disruptive events to the early-stage embryo while capturing images of embryos as they develop
  • Gems - the latest generation of Genea’s complete culture media suite for gamete and embryo handling and cultivation
  • Gidget - an innovative witnessing and tracking system that provides electronic witnessing, lab workflow management and support for traceability and audit reporting.
  • Gavi - the world’s first automated vitrification instrument using an automated, standardized protocol aiming to provide consistent results in gamete and embryo vitrification (not yet FDA-approved in the US).
About Hamilton Thorne
Hamilton Thorne (TSX-V: HTL) is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.  Hamilton Thorne has a team of 12 sales and technical support professionals working directly with ART providers in the US and Canada.